Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

ISSN： 1173-8804

Source： BioDrugs, Vol.10, Iss.6, 1998-12, pp. : 471-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David Lyseng-Williamson Katherine A.

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack Lesley J. Scott

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite

Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

By Simpson D. Noble S. Perry C.

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Relapsing-Remitting Multiple Sclerosis: What is the Potential for Combination Therapy?

By Mäurer M. Rieckmann P.

BioDrugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 149-158

Adis International

Access to resources Recommend Favorite

Interferon- -n1: A Review of its Pharmacological Properties and Therapeutic Efficacy in the Management of Chronic Viral Hepatitis

By Perry C.M. Wagstaff A.J.

BioDrugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 125-154

Adis International

Access to resources Recommend Favorite